Findings showed a 13.6% reduction in body weight in the semaglutide 25 mg group compared with a 2.2% reduction in the placebo group.

people with overweight or obesity had lost 5.9% of overall body weight after 3 months of using semaglutide. And after 6 months, they had lost 10.9%. Do you lose weight on a maintenance dose of Wegovy?

In patients with MASH and moderate or advanced liver fibrosis, once-weekly semaglutide at a dose of 2.4 mg improved liver histologic results. (Funded by Novo Nordisk; ClinicalTrials.gov number ...

A trial exploring the use of a higher dose of Novo Nordisk's GLP-1 agonist semaglutide has shown that patients with obesity who were taking the drug were able to shed more than a fifth of their ...

The key to unlocking the drug's potential will be a new trial due to start in the first half of this year that will include a new personalised approach to dosing with CagriSema and a longer period ...

[O]ral semaglutide 14 mg (or flexible dosing, in PIONEER 7) was generally more effective at improving multiple cardiometabolic risk factors — including HbA 1c, [body weight], SBP, and LDL ...

NCT05564117), a 64-week study that included a 12-week dose escalation and a 7-week off-treatment follow-up period. Study participants were randomly assigned 2:1 to receive oral semaglutide 25mg (n ...